[{"Assets_0_Q3_USD":137779773.0,"CommonStockSharesOutstanding_0_Q3_shares":59318355.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-56541468.0,"NetIncomeLoss_1_Q3_USD":-11438459.0,"NetIncomeLoss_3_Q3_USD":-37718286.0,"StockholdersEquity_0_Q3_USD":36118072.0,"Ticker":"ADMA","CIK":"1368514","name":"ADMA BIOLOGICS, INC.","OfficialName":"ADMA Biologics Inc Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"401636724.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191106"}]